The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
- Published In:
- International heart journal, 58(2), 257-263 (2017)
- Authors:
- Huang, Jiannan, Li, Yi(2), Zhang, Juan(2), Liu, Yusheng, Lu, Qinghua
- Database ID:
- RPEP-03325
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03325APA
Huang, Jiannan; Li, Yi; Zhang, Juan; Liu, Yusheng; Lu, Qinghua. (2017). The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.. International heart journal, 58(2), 257-263. https://doi.org/10.1536/ihj.16-241
MLA
Huang, Jiannan, et al. "The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.." International heart journal, 2017. https://doi.org/10.1536/ihj.16-241
RethinkPeptides
RethinkPeptides Research Database. "The Growth Hormone Secretagogue Hexarelin Protects Rat Cardi..." RPEP-03325. Retrieved from https://rethinkpeptides.com/research/huang-2017-the-growth-hormone-secretagogue
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.